Patent Oppositions in peptide synthesis industry

Explore the competitive field of peptide synthesis where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in peptide synthesis technology and learn how to protect your intellectual property.

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the peptide synthesis industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the peptide synthesis industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Oct 29, 2026
Patent NumberTitleApplicantOpposition DateOpposition Name
Use Of Perfusion Seed Cultures To Improve Biopharmaceutical Fed-Batch Production Capacity And Product QualityBIOGEN MAOct 21, 2026MAIWALD PATENTANWALTS
Use Of Perfusion Seed Cultures To Improve Biopharmaceutical Fed-Batch Production Capacity And Product QualityBIOGEN MAOct 20, 2026STRAWMAN
Use Of Myostatin Inhibitors And Combination TherapiesSCHOLAR ROCKOct 20, 2026CHUGAI SEIYAKU KABUSHIKI KAISHA
Methods And Compositions For Transducing And Expanding Lymphocytes And Regulating The Activity ThereofF1 ONCOLOGYOct 7, 2026PATENT BOUTIQUE
Binding Molecules For Bcma And Cd3AMGENOct 6, 2026STRAWMAN
Compositions And Methods Of Treating Lupus NephritisF HOFFMANN LA ROCHESep 30, 2026KERNEBECK PATENTANWALTS
Compositions And Methods Of Treating Lupus NephritisF HOFFMANN LA ROCHESep 30, 2026KERNEBECK PATENTANWALTS
Cytotoxicity-Inducing Therapeutic AgentCHUGAI SEIYAKU KABUSHIKI KAISHASep 29, 2026STRAWMAN
Compositions And Methods Of Treating Lupus NephritisF HOFFMANN LA ROCHESep 29, 2026WUESTHOFF & WUESTHOFF
Compositions And Methods Of Treating Lupus NephritisF HOFFMANN LA ROCHESep 29, 2026WUESTHOFF & WUESTHOFF

To stay ahead in the competitive peptide synthesis industry, companies are constantly innovating. Here are the top patents facing oppositions in the peptide synthesis industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Oct 29, 2026
Patent NumberPublication DateTitleApplicantTotal Oppositions
Mar 11, 2015Treatment Of Tnf Alpha Related DisordersABBVIE BIOTECHNOLOGY13
Jan 10, 2018Method To Improve Virus Removal In Protein PurificationGENENTECH11
Jan 18, 2017Methods Of Administering Anti-Tnfalpha AntibodiesABBVIE BIOTECHNOLOGY11
Nov 1, 2017Prevention Of Disulfide Bond Reduction During Recombinant Production Of PolypeptidesGENENTECH11
Nov 2, 2016Multiple-Variable Dose Regimen For Treating Tnfalpha-Related DisordersABBVIE BIOTECHNOLOGY11
Mar 2, 2022Modified Nucleoside, Nucleotide, And Nucleic Acid CompositionsMODERNA10
Sep 19, 2018Methods Of Cell CultureMOMENTA PHARMACEUTICALS10
May 15, 2019Combination Therapy For The Treatment Of Ovarian CancerF HOFFMANN LA ROCHE10
Feb 17, 2021Subcutaneously Administered Bispecific Antibodies For Use In The Treatment Of CancerLUDWIG MAXIMILIANS UNIVERSITT MNCHEN10
Feb 17, 2021Pharmaceutical Composition For Cancer TreatmentSHIONOGI10